Evidence map›Paper›PMID 30305910›Full record

ReviewOpen heart

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis.

Ali M Agha, Purvi Parwani, Avirup Guha, Jean B Durand, Cezar A Iliescu, Saamir Hassan, Nicolas L Palaskas, Greg Gladish, Peter Y Kim, Juan Lopez-Mattei

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Open heart. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Pre-test Prediction of Non-ischemic Cardiomyopathies using Time-Series EHR Data.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Correlation Between Quantitative Uptake ofFrontiers in cardiovascular medicine · 2021
    Article
  17. Article
  18. Article
  19. Should everyone have an MRI in heart failure?Cardiovascular diagnosis and therapy · 2020
    Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ali M AghaDepartment of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Purvi ParwaniDepartment of Cardiology, Loma Linda University Medical Center, Loma Linda, California, USA.
Avirup GuhaDivision of Cardiovascular Medicine, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-0253-1174
Jean B DurandCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cezar A IliescuCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Saamir HassanCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nicolas L PalaskasCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Greg GladishDiagnostic Radiology Department, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Peter Y KimCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Juan Lopez-MatteiCardiology Department, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-1177-8761
The University of Texas MD Anderson Cancer Center · USLoma Linda University Medical Center · USThe Ohio State University · USThe University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac amyloidosis (CA) describes the pathological process of amyloid protein deposition in the extracellular space of the myocardium. Unfortunately, the diagnosis of CA is often made late and when the disease process is advanced. However, advances in cardiovascular imaging have allowed for better prognostication and establishing diagnostic pathways with high sensitivity and specificity. This review discusses the role of echocardiography, cardiac MRI and nuclear cardiology in current clinical practice for diagnosis and prognosis of CA.

Indexed as

cardiac amyloidosiscardiac mricardiomyopathy restrictivecardio-oncologyglobal longitudinal strain

Identifiers

PMID30305910
PMCPMC6173267
OpenAlexW2893153122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.